Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-06

Clinical Trial Update: Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs

View source ↗

Summary

A completed clinical trial examines how genetic variation influences the efficacy and safety of lipid-lowering drugs in patients with acute coronary syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lipid-lowering drugs (statins) (statins)

Snippet

Sponsor: Assiut University | Conditions: Acute Coronary Syndromes | Status: COMPLETED